Karen Marie Johnson Receives Stock Award at Oncology Institute Inc (TOI) — SEC Form 4, Nov 24, 2025

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Karen Marie Johnson

Director

TXN 2025-11-20 · FILED 2025-11-24

Equity Position 288K sh 203,409 → 288,286

Equity Change +41.7% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Oncology Institute Inc

TOI CIK 0001799191

Reporting Owner

Name	Relationship
Karen Marie Johnson CIK 0001892819	Director

Karen Marie Johnson at Oncology Institute Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Oncology Institute Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2025-11-20	A - Award/Grant	47,840 A	$0.00	—	251,249	Direct
Common StockF2	2025-11-20	A - Award/Grant	37,037 A	$0.00	—	288,286	Direct

Footnotes (2)

F1: Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date. Show more
F2: Represents restricted stock units that were fully vested upon grant. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 3 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Oncology Institute Inc

GET /v1/forms/4/0001553350-25-000145 API docs